Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial
Bruno François(Inserm), Richard S. Hotchkiss(Washington University in St. Louis), Guillaume Monneret(Université Claude Bernard Lyon 1), Michel Morre, Matthew S. Shotwell(Vanderbilt University Medical Center), Andrew H. Walton(Washington University in St. Louis), Gail Mayo(Vanderbilt University Medical Center), Scott K. Durum(Center for Cancer Research), Jacqueline Unsinger(Washington University in St. Louis), Edward R. Sherwood(The University of Texas Medical Branch at Galveston), Thomas Daix, Teresa Blood(Washington University in St. Louis), Thomas Rimmelé(Université Claude Bernard Lyon 1), Robin Jeannet(Hôpital Universitaire Dupuytren), Anne Grégoire, Jane Blood(Washington University in St. Louis)
Cited by 412
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Sepsis and septic shock
|Nature Reviews Disease Primers|2016|1.6k
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
|Critical Care|2013|1.4k
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
|The Lancet Respiratory Medicine|2014|1.3k
The SOFA score—development, utility and challenges of accurate assessment in clinical trials
|Critical Care|2019|976